Additional European Equity News
News detail
Air France (AF FP) - Q4 (EUR): Revenue 8.19bln (exp. 8.1bln), Op. Result 393mln, -10% Y/Y. Group Passengers 24.6mln, +4.8% Y/Y. CEO: “Despite ongoing external uncertainty, we approach 2026 with confidence and a commitment to executing our strategic roadmap with rigor and discipline in order to reach our medium-term goals”. FY Outlook: Expects capacity up by +3-5% compared to 2025. (Air France) Zealand Pharma (ZEAL DC) - Revenue 9.22bln (exp. 9.23bln), Operating result 6.96bln (prev. -1.27bln Y/Y). 2026 Outlook: Net operating expenses 2.7-3.3bln (prev. recorded 2.10bln in 2025). (Zealand Pharma)
What do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
